Technical Analysis for NUVA - NuVasive, Inc.

Grade Last Price % Change Price Change
A 68.05 -0.96% -0.66
NUVA closed up 1.78 percent on Friday, April 9, 2021, on 53 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical NUVA trend table...

Date Alert Name Type % Chg
New 52 Week Closing High Bullish -0.96%
Bollinger Band Squeeze Range Contraction -0.96%
NR7 Range Contraction -0.96%
BB Squeeze + Upper Band Touch Range Contraction -0.96%
Above Upper BB Strength -0.96%
Upper Bollinger Band Touch Strength -0.96%
20 DMA Support Bullish 0.80%
Bollinger Band Squeeze Range Contraction 0.80%
20 DMA Support Bullish 3.33%
Bollinger Band Squeeze Range Contraction 3.33%
Older End-of-Day Signals for NUVA ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


NuVasive, Inc. Description

NuVasive, Inc., a medical device company, engages in the design, development, and marketing of minimally disruptive surgical products and procedurally integrated solutions for the spine. The company's products focus on applications for spine fusion surgery. It offers products for the thoracolumbar spine and the cervical spine primarily used to enable access to the spine and to perform restorative and fusion procedures in a minimally disruptive fashion. The company's principal products include a minimally disruptive surgical platform called Maximum Access Surgery (MAS), as well as cervical, biologics, and motion preservation products. Its MAS platform combines three categories of product offerings, including NVM5 and NVJJB, its proprietary software-driven nerve detection and avoidance systems, and intra-operative monitoring support services for insight into the nervous system during spine and other surgeries; MaXcess, an integrated split-blade retractor system; and various specialized implants. The company's biologic products include allograft, a donated human tissue; FormaGraft, a collagen synthetic product; Osteocel Plus, an allograft cellular matrix containing viable mesenchymal stem cells; and AttraX, a synthetic bone graft material. It also offers solutions for cervical fusion surgery, including allograft and CoRoent implants, as well as cervical plating and posterior fixation products. In addition, the company's products comprise PCM device, a motion preserving total disc replacement device; and XL TDR, a mechanical total disc replacement solution. NuVasive, Inc. sells its products through directly-employed sales shareowners, independent sales agents, and distributors to surgeons and hospitals in the United States and internationally. The company was founded in 1997 and is headquartered in San Diego, California.


Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Surgery Bone Stem Cells Spine Surgical Products Nerve Proprietary Software Neurosurgery Plating Integrated Solutions Logic Products Surgeries Collagen Biologic Product Biologic Products Bone Grafting Mesenchymal Stem Cell Spinal Fusion Transplantation Medicine Allotransplantation Avoidance Systems Neurosurgical Procedures Pcm Intervertebral Disc Arthroplasty

Is NUVA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 69.28
52 Week Low 43.11
Average Volume 687,175
200-Day Moving Average 54.62
50-Day Moving Average 61.77
20-Day Moving Average 66.39
10-Day Moving Average 66.20
Average True Range 2.14
ADX 30.83
+DI 27.07
-DI 11.48
Chandelier Exit (Long, 3 ATRs ) 62.86
Chandelier Exit (Short, 3 ATRs ) 66.93
Upper Bollinger Band 68.62
Lower Bollinger Band 64.17
Percent B (%b) 1.02
BandWidth 6.71
MACD Line 1.39
MACD Signal Line 1.48
MACD Histogram -0.0975
Fundamentals Value
Market Cap 3.52 Billion
Num Shares 51.3 Million
EPS 1.15
Price-to-Earnings (P/E) Ratio 59.90
Price-to-Sales 2.27
Price-to-Book 2.65
PEG Ratio 4.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 71.11
Resistance 3 (R3) 70.90 69.90 70.71
Resistance 2 (R2) 69.90 69.29 70.00 70.58
Resistance 1 (R1) 69.30 68.91 69.60 69.51 70.44
Pivot Point 68.30 68.30 68.45 68.40 68.30
Support 1 (S1) 67.71 67.69 68.00 67.91 66.98
Support 2 (S2) 66.70 67.31 66.80 66.84
Support 3 (S3) 66.11 66.70 66.71
Support 4 (S4) 66.31